Sales rise 29.58% to Rs 2033.97 crore
Net profit of Glenmark Pharmaceuticals rose 49.35% to Rs 555.83 crore in the quarter ended September 2016 as against Rs 372.17 crore during the previous quarter ended September 2015. Sales rose 29.58% to Rs 2033.97 crore in the quarter ended September 2016 as against Rs 1569.69 crore during the previous quarter ended September 2015. ParticularsQuarter EndedSep. 2016Sep. 2015% Var.Sales2033.971569.69 30 OPM %38.4129.99 -PBDT733.13488.74 50 PBT707.33463.69 53 NP555.83372.17 49Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
